Overview
Publication
Vaccine. 2017 Jun 16; 35(28):3558-3563.
PubMed ID: 28533053
Title
Exploring evidence for behavioral risk compensation among participants in an HIV vaccine clinical trial
Authors
Painter JE, DiClemente RJ, Jimenez L, Stuart T, Sales JM, Mulligan MJ
Abstract
HIV vaccine trial participants may engage in behavioral risk compensation due to a false sense of protection. We conducted an ancillary study of an HIV Vaccine Trials Network (HVTN) vaccine efficacy trial to explore risk compensation among trial participants compared to persons who were willing to participate but ineligible based on previous exposure to the Ad5 virus (Ad5+) across three timepoints.
With the publicly available data in the CAVD DataSpace we can Learn about studies, products, assays, antibodies, and publications, Find subjects with common characteristics, Plot assay results across studies and years of research, and Compare monoclonal antibodies and their neutralization curves. Data are also accessible via DataSpaceR, our R API.
Sign in to see full information about this publication and to download study data when available.